title: Long-standing remission of recalcitrant juvenile pemphigus vulgaris after adjuvant therapy with rituximab.
authors.forename: E
authors.initials: E
authors.lastname: Schmidt
authors.forename: S
authors.initials: S
authors.lastname: Herzog
authors.forename: E-B
authors.initials: EB
authors.lastname: Bröcker
authors.forename: D
authors.initials: D
authors.lastname: Zillikens
authors.forename: M
authors.initials: M
authors.lastname: Goebeler
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology; D004334:Drug Administration Schedule; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007155:Immunologic Factors / Q000008:administration & dosage*; D007262:Infusions, Intravenous; D008297:Male; D010392:Pemphigus / Q000188:drug therapy*; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D000276:Adjuvants, Immunologic; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D007074:Immunoglobulin G; D007155:Immunologic Factors; D000069283:Rituximab